Bifogade filer
Surgical Science Q3 2024 - Sequential improvements continue
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2024-11-15 13:08:00
Redeye updates its estimates following Surgical Science’s Q3 2024 report, which beat our expectations. Educational Products continued its sequential recovery, while solid Industry/OEM sales matched our projections. We expect a seasonally strong fourth quarter and solid growth in 2025e. We nudge up our estimates and valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/